RGCC Test
RGCC Test
Precision Insights For Proactive Cancer Defense
Precision Insights For Proactive Cancer Defense

An advanced test that analyzes circulating tumor cells (CTCs) and cancer stem cells in the blood to detect presence or risk of cancer—especially useful for early detection, monitoring, and treatment planning.
BENEFITS
- Detects cancer cells before symptoms arise
- Identifies which therapies are most effective (chemo-sensitivity)
- Monitors recurrence or metastasis
HOW IT WORKS
Blood is analysed using RGCC’s proprietary technology to detect and quantify circulating tumour cells and assess response to proposed treatments.
SUITABLE FOR
- High-risk individuals (family history, lifestyle risk factors)
- Cancer survivors (for recurrence monitoring)
- Patients seeking personalised cancer therapy options
APPLICATION
- Cancer risk screening
- Early cancer detection
- Oncology treatment planning
- Assessment of cancer treatment response